'Cancer does not wait, nor should cancer patients have to wait for years for their government to act,' health access advocates assert in a letter asking HHS to invoke 'march-in rights' to secure lower prices for the $190,000/yr prostate cancer drug Xtandi.
—under which the government can grant patent licenses to companies other than a drug's manufacturer—for enzalutamide, which is sold under the brand name Xtandi.
"Meanwhile," the letter continues,"HHS has not taken any action on our petition despite assurances" from the National Institutes of Health that the request would be reviewed within a month. Two companies—Japan-based Astellas and Medivation Inc., a San Francisco biotech firm—developed Xtandi. When Pfizer paid $14 billion to acquire Medivation in 2016, the pharma giant's then-CEO, Ian Read,that"the value of Xtandi and its future growth potential was the principal driver" of the deal.Los Angeles Times
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lung Cancer Awareness Month educates, urges action against the diseaseEvery year, more people die of lung cancer than colon, breast and prostate cancers combined.
Read more »
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer - NatureSpatial profiling and single-cell RNA sequencing are used to map the spatial distribution of the microbiota within human tumours, revealing how intratumoral microbial communities contribute to tumour heterogeneity and cancer progression.
Read more »
North Dakota millennial woman advances toward sainthood after the 'heroic sanctity' of her cancer battleMichelle Duppong of North Dakota is on a path toward being declared a saint in the Roman Catholic Church, as bishops approved advancing her cause for canonization in vote in Baltimore this week.
Read more »
What Cancer Takes AwayWhen Anne Boyer was diagnosed with cancer, she was treated with a drug known as “the red devil,” which turned her bodily fluids toxic to other people.
Read more »
San Jose Sharks host Hockey Fights Cancer event at SAP CenterThe SanJoseSharks hosted some special children for their game Thursday night in San Jose. Children fighting pediatric cancer were honored as part of a league-sponsored initiative called Hockey Fights Cancer.
Read more »
Ferroptosis of tumour neutrophils causes immune suppression in cancer - NaturePathologically activated neutrophils, termed myeloid-derived suppressor cells, in the tumour microenvironment spontaneously undergo ferroptosis, which negatively regulates anti-tumour immunity through the release of oxygenated lipids, therefore limiting the activity of human and mouse T cells.
Read more »